7.855
Schlusskurs vom Vortag:
$7.79
Offen:
$7.76
24-Stunden-Volumen:
116.16K
Relative Volume:
0.37
Marktkapitalisierung:
$398.29M
Einnahmen:
$1.05B
Nettoeinkommen (Verlust:
$-80.50M
KGV:
-4.8488
EPS:
-1.62
Netto-Cashflow:
$44.90M
1W Leistung:
+1.35%
1M Leistung:
-8.24%
6M Leistung:
+9.86%
1J Leistung:
-24.69%
Enhabit Inc Stock (EHAB) Company Profile
Firmenname
Enhabit Inc
Sektor
Branche
Telefon
(469) 621-6419
Adresse
6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS
Vergleichen Sie EHAB mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EHAB
Enhabit Inc
|
7.855 | 398.29M | 1.05B | -80.50M | 44.90M | -1.62 |
![]()
HCA
Hca Healthcare Inc
|
336.29 | 83.49B | 70.60B | 5.76B | 5.64B | 21.97 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
25.05 | 14.63B | 20.87B | 715.14M | 1.67B | 1.2209 |
![]()
DVA
Davita Inc
|
146.72 | 11.89B | 12.67B | 827.68M | 1.42B | 9.27 |
![]()
THC
Tenet Healthcare Corp
|
121.03 | 12.04B | 20.97B | 3.13B | 2.39B | 31.21 |
![]()
UHS
Universal Health Services Inc
|
175.53 | 11.60B | 15.42B | 1.03B | 956.84M | 15.02 |
Enhabit Inc Stock (EHAB) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
2024-05-14 | Hochstufung | Leerink Partners | Underperform → Market Perform |
2024-05-09 | Herabstufung | Jefferies | Buy → Hold |
2024-03-07 | Hochstufung | UBS | Sell → Neutral |
2023-12-12 | Eingeleitet | TD Cowen | Market Perform |
2023-06-20 | Eingeleitet | SVB Securities | Underperform |
2023-03-16 | Eingeleitet | Goldman | Neutral |
2022-12-13 | Eingeleitet | CJS Securities | Market Perform |
2022-12-08 | Eingeleitet | UBS | Sell |
2022-12-06 | Eingeleitet | Stifel | Buy |
2022-10-14 | Eingeleitet | Oppenheimer | Perform |
2022-08-30 | Eingeleitet | Jefferies | Buy |
2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
2022-08-18 | Eingeleitet | Citigroup | Neutral |
Alle ansehen
Enhabit Inc Aktie (EHAB) Neueste Nachrichten
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Enhabit challenged by hedge fund AREX Capital seeking seven board seatsreport - MSN
Enhabit, Inc.'s (NYSE:EHAB) Revenues Are Not Doing Enough For Some Investors - simplywall.st
Where are the Opportunities in (EHAB) - news.stocktradersdaily.com
Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors - Yahoo Finance
How Enhabit’s CEO battles for better Medicare Advantage rates - Modern Healthcare
At-Home Care Executives Bullish On Payer, Growth Strategies Heading Into Q2 - Home Health Care News
Enhabit cashes in on Medalogix stake By Investing.com - Investing.com Canada
Enhabit cashes in on Medalogix stake - Investing.com India
Enhabit, Inc. Sells Medalogix Stake for $21 Million - TipRanks
‘Disturbing’ Outlook: Hospices’ Top Regulatory Concerns in 2025 - Hospice News
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock - Yahoo Finance
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence - Joplin Globe
Enhabit Secures Prestigious Age-Friendly Recognition: What This Means for 370 Healthcare Locations - Stock Titan
Enhabit chief accounting officer sells $9,403 in stock By Investing.com - Investing.com South Africa
Enhabit chief accounting officer sells $9,403 in stock - Investing.com India
Enhabit, Inc. (NYSE:EHAB) Holdings Lifted by Rhumbline Advisers - Defense World
Enhabit, Inc. (NYSE:EHAB) Q4 2024 Earnings Call Transcript - MSN
Enhabit, Inc: Hold Rating Amid Mixed Segment Performance and Growth Challenges - TipRanks
Jefferies maintains Buy on Enhabit stock with $9.50 target By Investing.com - Investing.com India
Enhabit, Inc. Reports Q4 Results and 2025 Outlook - TipRanks
Enhabit, Inc. Navigates Growth Amid Challenges - TipRanks
Enhabit stock holds steady as Leerink maintains Market Perform rating By Investing.com - Investing.com South Africa
Enhabit, Inc. SEC 10-K Report - TradingView
Enhabit stock holds steady as Leerink maintains Market Perform rating - Investing.com India
Enhabit, Inc: Buy Rating Affirmed Amid Growth Potential and Stabilizing Fundamentals - TipRanks
Enhabit's De Novo Strategy Paying Off in 2025 - Hospice News
Earnings call transcript: Enhabit Inc Q4 2024 earnings miss, stock drops 12% - Investing.com
Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates - MSN
Enhabit: Q4 Earnings Snapshot - Midland Daily News
Enhabit Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Enhabit Q4 Earnings, Revenue Decline; Issues Outlook -March 05, 2025 at 05:42 pm EST - Marketscreener.com
Enhabit shares rise on upbeat 2025 earnings outlook - Investing.com India
Enhabit shares rise on upbeat 2025 earnings outlook By Investing.com - Investing.com South Africa
Enhabit, Inc. Reports Q4 2024 Financial Results - TipRanks
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance -March 05, 2025 at 04:58 pm EST - Marketscreener.com
Earnings Flash (EHAB) ENHABIT INC. Reports Q4 Revenue $258.2M, vs. FactSet Est of $259.1M - Marketscreener.com
Enhabit: Q4 Earnings Snapshot -March 05, 2025 at 05:41 pm EST - Marketscreener.com
Enhabit reports Q4 adjusted EPS 4c, consensus 5c - TipRanks
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance - The Bakersfield Californian
Y Intercept Hong Kong Ltd Has $307,000 Stock Holdings in Enhabit, Inc. (NYSE:EHAB) - Defense World
Finanzdaten der Enhabit Inc-Aktie (EHAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):